{"resourceType":"EvidenceVariable","id":"example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort","text":{"status":"generated","div":"\u003cdiv xmlns\u003d\"http://www.w3.org/1999/xhtml\"\u003e\n\t\t  \u003cp\u003e\n\t\t\tStroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis\n\t\t  \u003c/p\u003e\n\t\t\u003c/div\u003e"},"name":"Stroke Thrombolysis Trialists’ 2014-2016 IPD-MA Cohort","title":"Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis","status":"draft","relatedArtifact":[{"type":"citation","label":"Emberson 2014","display":"Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials.","citation":"Emberson J, Lees KR, Lyden P, Blackwell L, Albers G, Bluhmki E, et al;Stroke Thrombolysis Trialists\u0027 Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient data from randomised trials. Lancet 2014 Nov 29;384(9958):1929-35 PMID 25106063","document":{"url":"https://doi.org/10.1016/S0140-6736(14)60584-5"}},{"type":"citation","label":"Lees 2016","display":"Figure 2 Lees 2016","citation":"Lees KR, Emberson J, Blackwell L, Bluhmki E, Davis SM, Donnan GA, et al; Stroke Thrombolysis Trialists’ Collaborators Group. Effects of alteplase for acute stroke on the distribution of functional outcomes: a pooled analysis of 9 trials. Stroke. 2016;47:2373-2379. PMID 27507856","document":{"url":"https://doi.org/10.1161/STROKEAHA.116.013644"}}],"actual":true,"characteristic":[{"description":"Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis","defByCombination":{"code":"any-of","characteristic":[{"definitionReference":{"reference":"Group/ECASSIII-Trial-Cohort","type":"Group","display":"ECASS III Trial Cohort"}},{"definitionReference":{"reference":"Group/IST3-Trial-Cohort","type":"Group","display":"IST3 Trial Cohort"}},{"definitionReference":{"reference":"Group/ECASS-Trial-Cohort","type":"Group","display":"ECASS Trial Cohort"}},{"definitionReference":{"reference":"Group/ECASSII-Trial-Cohort","type":"Group","display":"ECASSII Trial Cohort"}},{"definitionReference":{"reference":"Group/EPITHET-Trial-Cohort","type":"Group","display":"EPITHET Trial Cohort"}},{"definitionReference":{"reference":"Group/ATLANTIS-Trial-Cohort","type":"Group","display":"ATLANTIS Trial Cohort"}},{"definitionReference":{"reference":"Group/NINDS-Trial-Cohort","type":"Group","display":"NINDS Trial Cohort"}}]}}]}